Live Hematology updates

Live Hematology news coverage of developments with the latest updates. Stay on top of latest Hematology news stories and find out what just happened, what is going on with Hematology. The latest real-time news updates and headlines on Hematology
Protein Block May Re-sensitize Chemo-resistant Tumors
Immune Variable Predicts Poor Cancer Outcomes
Iron Overload: Haemochromatosis Often Undiagnosed
Frankfurt Scientist Secures €2M Emmy Noether Grant
Minister Miller Issues Black History Month Statement
ASH Issues Guidelines for Diagnosing Light Chain Amyloidosis
Mount Sinai Charts Future for Personalized Cancer Vaccines
NextGenNK At ASH 2025
Theranostic Model Offers Hope for Gastric, Pancreatic Cures
Jakub Tolar Named New Baylor College of Medicine Chief
Autologous T Cell Therapy Targets Pancreatic Cancer
Pfizer's BRAFTOVI Boosts Response in Metastatic CRC
ADRIATIC Trial: Durvalumab Offers New Hope in SCLC Care
IV Iron: Cost-effective Anemia Treatment for Women
Cholesterol Drug Beats Chemo Resistance in TNBC
Immunotherapy Breakthrough: New Targets in Multiple Myeloma
Johns Hopkins Unveils Targeted T-Cell Cancer Therapy
MRNA Boosts Aging Immune Systems, Liver Rejuvenation
CAR-T Therapy Aids Rosemarie in Myeloma Battle
Research Reveals Rare Cancer Immunotherapy Side Effect
Stem Cell Role in Myelodysplastic Progression Unveiled
AI Model Boosts Early Breast Cancer Risk Assessment
Tec-Dara Combo Boosts Myeloma Treatment Efficacy
Advancing Autoimmune Bleeding Disorder Treatment
Pirtobrutinib Tops Standard Treatment for CLL/SLL
Drug Cuts Blood Transfusions in Non-Cardiac Surgery
Ianalumab Boosts Treatment Time in Immune Thrombocytopenia
Home Monitoring May Revolutionize T-Cell Therapy Care
ASH 2025: Pivekimab Sunirine Shows Promise in Two Blood Cancers
City of Hope Unveils Blood Cancer Breakthroughs at ASH
New T-Cell Gene Therapy Targets Incurable Leukemia
Blood Test May Predict CAR T-Cell Therapy Success
ASH 2025: Promising Phase 1 CAR-T Data for B-ALL
CAR T Cell Therapy Delays Tied to Preventable Toxicities
Miltenyi Unveils Key DALY 2-EU Trial Data at ASH Meeting
Non-Covalent BTKi Pirtobrutinib Promising for CLL/SLL
New Study Backs Chemo-Free Treatment for Ph+ ALL
Epcoritamab Boosts Second-line Follicular Lymphoma Care
Azacitidine-Venetoclax Tops Standard in AML Treatment
HYMPAVZI Cuts Bleeds 93% in Hemophilia A/B With Inhibitors
AI Links DNA Flaws to Blood Cancer: ASH 2025
Research: Safe Stem Cell Transplants From Mismatched Donors
New Stem Cell Method Succeeds Without Genetic Match
CLL Treatment Outcomes Similar for Continuous, Fixed Plans
MRD: Promising Early Survival Indicator in AML Patients
Chemo, Radiation Equal for Pre-Transplant in B-ALL Patients
Families With Leukemia Kids Struggle Financially
Project Boosts Iron Deficiency Screening in Pregnancy